VIRTUAL BRANDED EDUCATION – Learn About HYMPAVZI™ (marstacimab-hncq)

Join us for a virtual educational session presented by Pfizer to learn more about Hympavzi a rebalancing treatment option for hemophilia. This session is intended for people living with hemophilia, parents, partners, and caregivers, and anyone interested in learning more about treatment options and shared decision-making with a health care provider.

You’ll hear:
• The science behind rebalancing therapy
• Clinical trial data
• Safety information
• Information on administration
• Shared decision-making tips for patients and caregivers

Speaker: Linda L. Pollhammer, Patient Affairs Liaison, Pfizer Rare Disease

Important notes

This is a branded educational program presented in partnership with Pfizer. The information shared is for educational purposes and is not medical advice. Always talk with your hemophilia treatment center (HTC) or health care provider about what’s right for you.

Thank you to our sponsor, Pfizer, for supporting this program.